Molecule associated with autism: Folic acid. Do we use it correctly?

dc.contributor.authorSenol, Deniz
dc.contributor.authorKarataş, Mehmet
dc.contributor.authorKarataş, Turgay
dc.contributor.authorÖzbağ, Davut
dc.contributor.authorTecellioğlu, Mehmet
dc.contributor.authorCanbolat, Mustafa
dc.date.accessioned2021-10-27T09:14:39Z
dc.date.available2021-10-27T09:14:39Z
dc.date.issued2019
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAbstract: Aim: Neural tube defects (NTD) are among most commonly found congenital anomalies. Sufficient amount of folic acid taken in preconception period is reported to prevent NTD development. There are studies in literature which make an association between high doses of folic acid taken during pregnancy and autism. When folic acid supplement began to be made on foods to protect from neural tube defects a concurrent increase has been mentioned in autism prevalence. Today pregnancy and folic acid supplement are currently indispensable. Physicians have made this supplement a routine. Aim of study is to assess if every woman in Malatya has a deficiency which requires routine use of folic acid through the folic acid levels of women who refer to health institutions. Material and Methods: Study conducted on the records of 1003 female patients in reproductive age group who referred to neurology and internal medicine polyclinics for any reason and whose folic acid levels were checked by the related physician. Results: Serum folic acid level averages of all women whose records were taken is 7,69±3,03ng/ml. Only 27 (2,69%) women’s folic acid levels lower than 3,08 ng/ml. 699 (69,69%) women’s serum folic acid levels higher than 6 ng/ml. Conclusions: If these 1003 women were pregnant, they would routinely be started folic acid. However, folic acid levels of a great majority (69,69%) was found to be higher than 6 ng/ml. We believe that physicians should start folic acid after taking into consideration the nutritional habits and socioeconomic characteristics of the region they live in and after they check serum folic acid level.en_US
dc.identifier.citationCANBOLAT M,TECELLİOĞLU M,ÖZBAĞ D,KARATAŞ T,KARATAŞ M,SENOL D (2019). Molecule associated with autism: Folic acid. Do we use it correctly?. Annals of Medical Research, 26(2), 139 - 143. Doi: 10.5455/annalsmedres.2018.09.202en_US
dc.identifier.doi10.5455/annalsmedres.2018.09.202en_US
dc.identifier.endpage143en_US
dc.identifier.issn2636-7688
dc.identifier.issue2en_US
dc.identifier.startpage139en_US
dc.identifier.trdizinid315681en_US
dc.identifier.urihttps://doi.org/10.5455/annalsmedres.2018.09.202
dc.identifier.urihttps://hdl.handle.net/11616/42528
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/315681
dc.identifier.volume26en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofAnnals of Medical Researchen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleMolecule associated with autism: Folic acid. Do we use it correctly?en_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Öz.docx
Boyut:
13.97 KB
Biçim:
Microsoft Word XML
Açıklama:
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: